Population pharmacokinetics of higher-dose mizoribine in healthy male volunteers

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 12, 2006, Pages 2460-2464

  Honda, Mutsuko ^a   Itoh, Hiromichi ^b   Suzuki, Tadakiyo ^b   Hashimoto, Yukiya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

Bayesian analysis; Mizoribine; Nonlinear mixed effect model; Population pharmacokinetics

Indexed keywords

MIZORIBINE;

ADULT; ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG MEGADOSE; HUMAN; HUMAN EXPERIMENT; MALE; PARAMETER; POPULATION RESEARCH; SINGLE DRUG DOSE; TABLET FORMULATION;

ADULT; BAYES THEOREM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REFERENCE VALUES; RIBONUCLEOSIDES;

EID: 33845369534     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2460     Document Type: Article

References (18)

1. Takei S., Pediatr. Int., 44, 205-209 (2002).
2. Matsumoto K., Morino T., Hara T., Yano J., Tujino M., Mizuno K., Yamamoto H., Jpn. J. Transplant., 17, S603-614 (1982).
3. Murase J., Mizuno K., Kawai K., Nishiumi S., Kobayashi Y., Hayashi M., Morino T., Suzuki T., Baba S., Pharmacometrics, 15, 829-835 (1978) (in Japanese).
4. Akiyama T., Okazaki H., Takahashi K., Hasegawa A., Tanabe K., Uchida K., Takahara S., Toma H., Transplant. Proc., 37, 843-845 (2005).
5. Stypinski D., Obaidi M., Combs M. L., Weber M. E., Stewart A. J., Ishikawa H., Br. J. Clin. Pharmacol. (in press).
6. Beal S. L., Boeckmann A. J., Sheiner L. B., "NONMEM Users Guides: NONMEM Project Group," University of California, San Francisco, 1992.
7. Hosotsubo H., J. Chromatogr., 432, 340-345 (1988).
8. de Jonge M. E., Huitema A. D., Rodenhuis S., Beijnen J. H., Ther. Drug Monit., 27, 393-402 (2005).
9. Gray J. H., Owen R. P., Giacomini K. M., Pflugers Arch., 447, 728-734 (2004).
10. Patil S. D., Ngo L. Y., Glue P., Unadkat J. D., Pharm. Res., 15, 950-952 (1998).
11. Fernandez H., Banks G., Smith R., Eur. J. Epidemiol., 2, 1-14 (1986).
12. Okada M., Suzuki K., Nakashima M., Nakanishi T., Fujioka N., Eur. J. Pharmacol., 531, 140-144 (2006).
13. Liu D., Kobayashi T., Nagasaka T., Yokoyama I., Ma Y., Miwa Y., Kuzuya T., Morozumi K., Oikawa T., Shimano Y., Takeuchi O., Uchida K., Nakao A., Transpl. Int., 18, 401-407 (2005).
14. Koyama H., Tsuji M., Biochem. Pharmacol., 32, 3547-3553 (1983).
15. Abe Y., Tsuji Y., Hisano M., Nakada M., Miura K., Watanabe S., Odajima Y., Iikura Y., Pediatr. Int., 46, 597-600 (2004).
16. Yoshioka K., Ohashi Y., Sakai T., Ito H., Yoshikawa N., Nakamura H., Tanizawa T., Wada H., Maki S., Kidney Int., 58, 317-324 (2000).
17. Tanaka H., Tsugawa K., Nakahata T., Kudo M., Onuma S., Kimura S., Ito E., Tohoku J. Exp. Med., 205, 87-91 (2005).
18. Tanaka H., Tsugawa K., Suzuki K., Nakahata T., Ito E., Pediatr. Nephrol., 21, 962-966 (2006).